首页|期刊导航|广州医药|血清TMAO水平与维持性血液透析患者预后的关联性:一项单中心前瞻性队列研究

血清TMAO水平与维持性血液透析患者预后的关联性:一项单中心前瞻性队列研究OA

Association of serum TMAO levels with prognosis in maintenance hemodialysis patients:A single-center prospective cohort study

中文摘要英文摘要

目的 探讨血清氧化三甲胺(TMAO)对维持性血液透析(MHD)患者心脑血管死亡的预测价值.方法 采用前瞻性队列观察性研究设计,纳入98例MHD患者.基线检测血清TMAO,随访至发生终点事件或研究截止,终点事件为心脑血管死亡.采用单因素及Firth修正多因素Cox比例风险模型、Kaplan-Meier生存分析探讨TMAO与预后的关系.结果 基线TMAO中位数为76.85 μmol/L.单因素分析显示,基线血清TMAO升高与心脑血管死亡风险增加相关(HR=1.005 2,95%CI:1.000 6~1.009 8,P=0.027 8);血红蛋白为保护因素(HR=0.973 3,95%CI:0.947 4~0.999 8,P=0.048 2);下肢血管病变者心脑血管死亡风险显著升高(HR=4.249 4,95%CI:1.377 6~11.855 3,P=0.014 0).以187.15 μmol/L 为截断值,TMAO高水平组心脑血管死亡风险显著增高(HR=3.53,95%CI:1.18~10.56,P=0.016).结论 本研究结果提示,高血清TMAO水平可用于识别MHD患者的心脑血管死亡高危人群,临床监测血液透析患者血清TMAO浓度有助于开展更精准的心血管风险分层管理与个体化靶向干预策略,对改善患者的不良结局有着重要的临床价值.

Objective To investigate the predictive value of serum trimethylamine N-oxide(TMAO)level for cardio-cerebrovascular mortality in maintenance hemodialysis(MHD)patients.Methods A prospective observational cohort study was conducted.A total of 98 MHD patients were enrolled,and serum TMAO was measured at baseline.Participants were followed up until the occurrence of the endpoint or the end of the study.The endpoint was defined as cardiovascular and cerebrovascular death.Univariate and Firth-corrected multivariate Cox proportional hazards models,together with Kaplan-Meier survival analysis,were applied to evaluate the relationship between TMAO and prognosis.Results The median baseline serum TMAO level was 76.85 μmol/L.Univariate analysis demonstrated that elevated baseline serum TMAO was associated with an increased risk of cardio-cerebrovascular mortality(HR=1.005 2,95%CI:1.000 6-1.009 8,P=0.027 8).Hemoglobin was a protective factor(HR=0.973 3,95%CI:0.947 4-0.999 8,P=0.048 2).Patients with lower extremity vascular disease had a significantly higher risk of cardio-cerebrovascular mortality(HR=4.249 4,95%CI:1.377 6-11.855 3,P=0.014 0).Using 187.15 μmol/L as the cutoff value,the high TMAO group exhibited a markedly increased risk of cardio-cerebrovascular mortality(HR=3.53,95%CI:1.18-10.56,P=0.016).Conclusions The findings indicate that high serum TMAO level can be used to identify MHD patients at high risk of cardio-cerebrovascular mortality.Clinical monitoring of serum TMAO concentration in hemodialysis patients facilitates precise cardiovascular risk stratification and individualized targeted intervention,which is of important clinical value in improving adverse outcomes of these patients.

黄家莲;吕路;卢景辉;韦佳妤;陈三三;马金火

广东药科大学附属第一医院肾内科(广东 广州 510080)广东药科大学附属第一医院肾内科(广东 广州 510080)广东药科大学附属第一医院检验科(广东 广州 510080)广东药科大学护理学院(广东 广州 510310)广东药科大学附属第一医院泌尿外科(广东 广州 510080)广东药科大学附属第一医院病案统计科(广东 广州 510080)

氧化三甲胺血液透析心血管事件预后

trimethylamine N-oxidehemodialysiscardiovascular eventsprognosis

《广州医药》 2026 (8)

967-974,8

广东省医学科研基金(C2022098)

10.20223/j.cnki.1000-8535.2026.08.007

评论